Loading clinical trials...
Loading clinical trials...
NY-ESO-1 Protein Immunization of Post-Cystectomy or Post-Nephroureterectomy Patients With Transitional Cell Carcinomas
Conditions
Interventions
TICE®-strain BCG
NY-ESO-1 protein
+1 more
Locations
1
United States
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Start Date
October 28, 2003
Primary Completion Date
January 3, 2006
Completion Date
September 30, 2013
Last Updated
October 12, 2022
NCT07485114
NCT01167712
NCT04739800
NCT02111941
NCT03081858
NCT05052372
Lead Sponsor
Ludwig Institute for Cancer Research
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions